Gajewski TF - Search Results

1

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment.

Gajewski TF. Gajewski TF. Semin Oncol. 2015 Aug;42(4):663-71. doi: 10.1053/j.seminoncol.2015.05.011. Epub 2015 Jun 3. Semin Oncol. 2015. PMID: 26320069 Free PMC article. Review.

2

Regulation of T-cell activation: differences among T-cell subsets.

Gajewski TF, Schell SR, Nau G, Fitch FW. Gajewski TF, et al. Immunol Rev. 1989 Oct;111:79-110. doi: 10.1111/j.1600-065x.1989.tb00543.x. Immunol Rev. 1989. PMID: 2534116 Review.

3

Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Gajewski TF, Fitch FW. Gajewski TF, et al. J Immunol. 1988 Jun 15;140(12):4245-52. J Immunol. 1988. PMID: 2967332

4

Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells.

Fallarino F, Ashikari A, Boon T, Gajewski TF. Fallarino F, et al. Among authors: gajewski tf. Int Immunol. 1997 Sep;9(9):1259-69. doi: 10.1093/intimm/9.9.1259. Int Immunol. 1997. PMID: 9310829

5

Rational development of tumour antigen-specific immunization in melanoma.

Gajewski TF, Fallarino F. Gajewski TF, et al. Ther Immunol. 1995 Aug;2(4):211-25. Ther Immunol. 1995. PMID: 9358613 Review.

6

B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.

Fallarino F, Fields PE, Gajewski TF. Fallarino F, et al. Among authors: gajewski tf. J Exp Med. 1998 Jul 6;188(1):205-10. doi: 10.1084/jem.188.1.205. J Exp Med. 1998. PMID: 9653097 Free PMC article.

7

B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.

Fields PE, Finch RJ, Gray GS, Zollner R, Thomas JL, Sturmhoefel K, Lee K, Wolf S, Gajewski TF, Fitch FW. Fields PE, et al. Among authors: gajewski tf. J Immunol. 1998 Nov 15;161(10):5268-75. J Immunol. 1998. PMID: 9820499 Free article.

8

The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response.

Markiewicz MA, Gajewski TF. Markiewicz MA, et al. Among authors: gajewski tf. Crit Rev Oncog. 1999;10(3):247-60. Crit Rev Oncog. 1999. PMID: 10468184 Review.

9

Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide.

Rini BI, Gajewski TF. Rini BI, et al. Among authors: gajewski tf. Ann Oncol. 1999 Aug;10(8):973-9. doi: 10.1023/a:1008321802223. Ann Oncol. 1999. PMID: 10509161 Free article. Review.

10

Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1.

Fallarino F, Gajewski TF. Fallarino F, et al. Among authors: gajewski tf. J Immunol. 1999 Oct 15;163(8):4109-13. J Immunol. 1999. PMID: 10510345 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results